Find More Contacts for MacroGenics
Protected Content
CEO, Director, President
Non-Management, Executive Management
2 emails found 1 phone number found
View contacts for MacroGenics to access new leads and connect with decision-makers.
View All Contacts
  • Contact Email info@macrogenics.com
  • Phone Number +1-3012515321

MacroGenics, Inc., a biotechnology company, focuses on the development, manufacture, and commercialization of immunotherapeutics for autoimmune disorders, cancer, and infectious diseases.

The company is developing immune-based products, including monoclonal antibodies; and vaccines to prevent infections in healthy individuals. The company's

Fc engineering technology enables to improve antibody functions to eliminate cancer cells. It is also developing products around the Dual Activating ReTargeting technology.

The company was founded in 2000 and is headquartered in Rockville, Maryland.

Lists Featuring This Company

TPG Portfolio Companies
180 Number of Organizations â€¢ $153.3B Total Funding Amount â€¢ 1,941 Number of Investors
United States Public Companies With More Than 10 Employees
5,248 Number of Organizations â€¢ $1.8T Total Funding Amount â€¢ 15,252 Number of Investors
Manufacturing Public Companies With More Than 100 Employees
8,488 Number of Organizations â€¢ $536.7B Total Funding Amount â€¢ 2,820 Number of Investors
United States Public Companies With Fewer Than 1000 Employees
4,439 Number of Organizations â€¢ $548.2B Total Funding Amount â€¢ 11,138 Number of Investors

Frequently Asked Questions

Where is MacroGenics's headquarters? MacroGenics is located in Rockville, Maryland, United States.Who invested in MacroGenics? MacroGenics has 25 investors including National Institutes of Health and Nextech Venture.How much funding has MacroGenics raised to date? MacroGenics has raised .When was the last funding round for MacroGenics? MacroGenics closed its last funding round on Feb 12, 2019 from a Post-IPO Equity round.Who are MacroGenics's competitors? Alternatives and possible competitors to MacroGenics may include Arrowhead PharmaceuticalsCEL-SCI, and Gelesis.